9th November 2020 | Regulatory reports
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
5th October 2020 | Regulatory reports
This report takes a state-by-state look at the status of CBD in foods in the US, detailing the current framework and status
3rd August 2020 | Regulatory reports
Confusion over whether CBD should be considered a narcotic drug has developed into a major question mark over the substance’s future in Europe
31st July 2020 | Market reports
This report addresses the evolution of the pet product category and the common characteristics and main differences between eight European countries and the US, covering product segmentation and pricing
2nd July 2020 | Regulatory reports
This report investigates the current situation with respect to advertising CBD products via the most widely used social media platforms
11th May 2020 | Regulatory reports
This short regulatory report provides an overview of the current GMP regulations for cosmetics being place on the market in the EU
30th April 2020 | Business briefing
In order to help you keep track of how all this is affecting the CBD industry around the world, all CBD-Intel’s COVID-19-related coverage can now be found in one place here
29th April 2020 | Market reports
This report identifies and contextualises any pricing differences across CBD products and markets around the world
27th April 2020 | Regulatory reports
With the federal legalisation of hemp in the US , states were left to enact their own legislation to adapt. CBD-Intel provides an overview of US law on smokable hemp, along with analysis of each state’s rules
9th April 2020 | Regulatory reports
Not all European markets offer the same business opportunities, and while some countries offer few some others do allow some CBD businesses to flourish in some areas. This report covers regulation of herbal smoking products in Europe
17th February 2020 | Regulatory reports
This regulatory report looks at Intellectual Property law in relation to CBD and hemp products, focusing specifically on trademarks and patents and their requirements
13th February 2020 | Regulatory reports
The aim of this report is to bring some clarity to the process of placing a food product on the EU market, looking at the options of Article 4 and Article 10
10th December 2019 | Regulatory reports
This report examines the legal scope of the use of CBD in sport within the principal sport organisations based in North America and Europe. More specifically, it looks at the position and policies of major leagues and sports organisations, and the ability of CBD hemp companies to sponsor sport teams.
25th November 2019 | Regulatory reports
The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product categories on the market: edibles
22nd November 2019 | Regulatory reports
CBD-Intel examines possible exemptions for some small packages in EU regulations concerning classification, labelling and packaging (CLP)
30th September 2019 | Regulatory reports
This report provides an overview of the applicable framework for the movement of hemp and CBD within the borders of the EU as well as the import and export to and from “third countries”
24th September 2019 | Regulatory reports
This report continues to look at the European Union’s CLP regulations and covers hazardous chemicals and obligations to notify, the part played by Poison Centres and the need for UFIs
24th September 2019 | Regulatory reports
The EU’s Classification, Labelling and Packaging (CLP) Regulations classify all chemical substances and mixtures according to their toxicity levels. Part 1 of our report looks in detail at this legislation
20th September 2019 | Regulatory reports
CBD for vaping is not as cut-and-dried as you might hope, despite vaping products having a clear regulatory regime in Europe. CBD-Intel looks at the different rules for CBD and vaping across the EU.
10th April 2019 | Regulatory briefing
CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity
26th March 2019 | Regulatory reports
Under current EU rules, cannabinoid-containing hemp extracts could require pre-market authorisation as they are now considered to be novel foods. CBD-Intel explains how the rules work
21st February 2019 | Regulatory reports
According to EU authorities, CBD and other cannabis extracts could be deemed illegal as an ingredient in cosmetics. However, individual member states have not made the same interpretation of the rules
22nd January 2019 | Regulatory briefing
No food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities – though this is open to interpretation
7th January 2019 | Regulatory reports
The CBD industry is currently navigating a complex and changing regulatory landscape across the European Union. CBD-Intel brings some light to the obscure area of novel food regulation – and asks the vital questions
9th May 2018 | Regulatory reports
What laws regulate the use of cannabidiol (CBD) in e-liquids across the European Union – and what regulatory regime is likely to apply in the future? Our report finds the clear lines in a legal grey area
24th February 2021 | Regulatory briefing
A US association of cannabis regulators has written to Congress urging the modernisation of cannabis policy at federal level
23rd February 2021 | Business briefing
British American Tobacco (BAT) is looking “beyond nicotine” to alternative sources of revenue, and has described CBD as an “exciting growth area for our business for the future”
23rd February 2021 | Regulatory briefing
The legalisation of recreational cannabis in South Dakota is in doubt, amidst accusations of political interference after a judge appointed by the state governor ruled the voter-approved amendment unconstitutional
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the oils category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the topicals category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the edibles category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the capsules category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the concentrates category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on the vape category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the German CBD market between the third and fourth quarters of 2020, focusing specifically on the pet products category
22nd February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in Germany between the third and fourth quarters of 2020, focusing specifically on other cannabinoids
22nd February 2021 | Market trackers
This interactive dashboard provides essential pricing data for product categories offered by the top German CBD brands.
With this tool you will be able to:
Understand the current price positions for eight CBD categories.
Analyse price reduction activity within each category.
Analyse price positioning of new product entrants.
Strategically set pricing against the market and competitors.
Tailor product development.
22nd February 2021 | Market trackers
Welcome to the CBD-Intel top brands dashboard, for insights into Germany’s most pertinent CBD brands. Find all product offerings for each brand, categorised by type of product, size, format, CBD content and their respective prices.
18th February 2021 | Regulatory briefing
The US Federal Trade Commission (FTC) could take a more discerning approach to enforcement against CBD companies under the new administration in Washington
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the oils category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the edibles category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the topicals category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the capsules category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the concentrates category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on the vape category
16th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the UK between the third and fourth quarters of 2020, focusing specifically on other cannabinoids
15th February 2021 | Regulatory reports
The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD
15th February 2021 | Market trackers
This interactive dashboard provides essential pricing data for product categories offered by the top UK CBD brands.
With this tool you will be able to:
Understand the current price positions for eight CBD categories.
Analyse price reduction activity within each category.
Analyse price positioning of new product entrants.
Strategically set pricing against the market and competitors.
Tailor product development.
15th February 2021 | Market trackers
Welcome to the CBD-Intel top brands pricing dashboard, for insights into the UK’s most pertinent CBD brands. Find all product offerings for each brand, categorised by type of product, size, format, CBD content and their respective prices.
The interactive dashboard allows you to slice data using the filters on the left, enabling you to investigate market strategies and trends. Furthermore, you may read the analytical UK pricing report to gain a complete understanding of the market.
12th February 2021 | Regulatory briefing
Reports that the UK Home Office now requires businesses importing CBD into the UK to have controlled drug licences are untrue, according to the Home Office
11th February 2021 | Regulatory briefing
The Democratic Party, which now controls Congress and the presidency, has signalled for some time that cannabis reform is one of its top priorities, and the US public supports that reform in unprecedented numbers
10th February 2021 | Regulatory briefing
US president Joe Biden’s appointees to a number of influential positions in the new administration give reason for optimism within the hemp and cannabis sector
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape for CBD products in the US between the third and fourth quarters of 2020
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the oils category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the edibles category (including drinks)
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the capsules category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the vapour category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the concentrates category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the topicals category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the flower category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the pet products category
10th February 2021 | Market reports
This report addresses the changes to the product offering and brand landscape in the US CBD market between the third and fourth quarters of 2020, focusing specifically on the other cannabinoids category
9th February 2021 | Market trackers
Welcome to the CBD-Intel top brands dashboard, for insights into the US most pertinent CBD brands. Find all product offerings for each brand, categorised by type of product, size, format, CBD content and their respective prices.
9th February 2021 | Market trackers
This interactive dashboard provides essential pricing data for product categories offered by the top US CBD brands.
With this tool you will be able to:
Understand the current price positions for eight CBD categories.
Analyse price reduction activity within each category.
Analyse price positioning of new product entrants.
Strategically set pricing against the market and competitors.
Tailor product development.
8th February 2021 | Regulatory reports
Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules
5th February 2021 | Business briefing
CBD firms are making further advances into the health and wellness subcategory of the market with new product launches, distribution deals, and clinical studies underway
3rd February 2021 | Business briefing
GW Pharmaceuticals, the British manufacturer of the CBD-based epilepsy drug Epidiolex, has been acquired by Jazz Pharmaceuticals in a cash and shares deal worth over $7bn
1st February 2021 | Regulatory briefing
The US Small Business Administration (SBA) has highlighted its role in securing changes to the Department of Agriculture (USDA)’s final rule for hemp production
1st February 2021 | Business briefing
Specific UK guidance for producers of drinks containing both alcohol and CBD will be developed after the first complaint against one such brand was upheld by the voluntary regulating body for the UK drinks industry
28th January 2021 | Business briefing
Pyxus International, a major supplier of products to the tobacco and vaping sectors, is to sell off its cannabis-related business while restructuring its industrial hemp and CBD operations
28th January 2021 | Regulatory briefing
Two German parliamentary groups have submitted a joint initiative to remove industrial hemp from the Narcotics Act and raise the THC limit from 0.2% to at least 0.6%
27th January 2021 | Regulatory briefing
CBD extracted from the whole Cannabis sativa plant will be allowed in cosmetic products in the EU, according to a preliminary conclusion by the European Commission conveyed to CBD-Intel
27th January 2021 | Business briefing
British CBD brands are suspending shipping to the EU, European customers are hit by unexpected import fees, and UK entrepreneurs are struggling to establish their start-ups, as Brexit regulations cause chaos
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.